Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Oncoimmunology|May 24, 2021
PPARγ induces PD-L1 expression in MSS+ colorectal cancer cellsTobias Gutting, Veronika Hauber, Jens Pahl, et al.
Cell Communication and Signaling : CCS|May 28, 2026
Ras-MAPK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesisNachiyappan Venkatachalam, Li Wang, Niyumi Muthukumarana, et al.
The Lancet. Healthy Longevity|September 13, 2022
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trialMatthias P Ebert, Nadja M Meindl-Beinker, Tobias Gutting, et al.
Nature Communications|June 6, 2022
The drug-induced phenotypic landscape of colorectal cancer organoidsJohannes Betge, Niklas Rindtorff, Jan Sauer, et al.
Journal of Translational Medicine|November 18, 2023
WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosisPanpan Tai, Xinyu Chen, Guihua Jia, et al.
NPJ Genomic Medicine|May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patientsTom Venken, Ian S Miller, Ingrid Arijs, et al.
Pageof 6